ASX-listed Nanosonics, Optiscan, and Clever Culture Systems are transforming healthcare efficiency through innovative medtech ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

During a discussion with former Oregon Sen. Gordon Smith on Thursday, Cotton argued that the foreign policy of Trump is “not ...

Explore the potential threats and risks impacting the pharmaceutical industry in 2024, including considerations such as protests, risk analysis, and the influence of environmental, social, and ...

Discover how artificial intelligence is revolutionising the pharmaceutical industry and how it can potentially save time, resources, and lives. Learn more about the impact of AI on pharma and ...

Plus, Ghislaine Maxwell's transfer to a minimum security prison sparks outrage, and the 80th anniversary of Hiroshima.

In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed ...

Our system provides the best of both worlds: development of new drugs and cheap options for most prescriptions. | Opinion ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have ...

The booming supplement industry promises better sleep, sharper focus, and even "liver detox"—all wrapped in the comforting ...

Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials, a critical competency for legal and business professionals in the biopharmaceutical arena.

The Food and Drug Administration is launching a new program to ramp up the United States’ domestic pharmaceutical supply chain, the agency announced Thursday. The program, called FDA ...